Corrigendum to “Hepatitis B birth dose vaccination for newborns in Uganda: A qualitative inquiry on pregnant women’s perceptions, barriers and preferences”

Abstract
The full acknowledgment for the article is restated herein: This research (or [initials]) was supported by the Consortium for Advanced Research Training in Africa (CARTA). CARTA is jointly led by the African Population and Health Research Center and the University of the Witwatersrand and funded by the Carnegie Corporation of New York (Grant No—G-19-57145), Sida (Grant No:54100113), Uppsala Monitoring Center and the DELTAS Africa Initiative (Grant No: 107768/Z/ 15/Z). The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)’s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa’s Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust (UK) and the UK government. The statements made and views expressed are solely the responsibility of the Fellow.
Description
Keywords
Hepatitis B birth dose vaccination, Newborns, Pregnant women’s perceptions, Uganda
Citation
Mutyoba, J. N., Surkan, P. J., Makumbi, F., Aizire, J., Kirk, G. D., Ocama, P., & Atuyambe, L. M. (2021). Corrigendum to “Hepatitis B birth dose vaccination for newborns in Uganda: A qualitative inquiry on pregnant women's perceptions, barriers and preferences”[J Virus Eradic 7 (2)(2021) 100039]. Journal of Virus Eradication, 7(3).https://doi.org/10.1016/j.jve.2021.100051